Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Richard Close maintains a Hold rating on HealthStream (NASDAQ:HSTM) and raises the price target from $27 to $28.
July 24, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst Richard Close maintains a Hold rating on HealthStream and raises the price target from $27 to $28.
The raised price target from $27 to $28 indicates a positive outlook from the analyst, which could lead to a short-term increase in stock price. However, the Hold rating suggests limited upside potential.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100